Consider the role of corneal nerves in dry eye disease

Scott Schachter, OD, discusses neuropathic and neurotrophic differentials in managing dry eye disease.

Related: Quick reminders for managing dry eye

Related Videos
Related Content

3-week therapeutics for MGD equivalent to 6-week treatment in efficacy and adverse events

March 27th 2023

Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

September 24th 2021

MOJAVE phase 3 study results published

March 22nd 2023

Podcast: Alliance for Patient Safety chair talks contact lenses and the FTC

January 22nd 2021

Artificial tear ingredients that mimic the real thing

March 14th 2023

First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease

March 2nd 2023

3-week therapeutics for MGD equivalent to 6-week treatment in efficacy and adverse events

March 27th 2023

Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

September 24th 2021

MOJAVE phase 3 study results published

March 22nd 2023

Podcast: Alliance for Patient Safety chair talks contact lenses and the FTC

January 22nd 2021

Artificial tear ingredients that mimic the real thing

March 14th 2023

First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease

March 2nd 2023

3-week therapeutics for MGD equivalent to 6-week treatment in efficacy and adverse events

March 27th 2023

Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

September 24th 2021

MOJAVE phase 3 study results published

March 22nd 2023

Podcast: Alliance for Patient Safety chair talks contact lenses and the FTC

January 22nd 2021

Artificial tear ingredients that mimic the real thing

March 14th 2023

First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease

March 2nd 2023
© 2023 MJH Life Sciences

All rights reserved.